Insulet Corporation (podd)
PODD Ownership
Institutional holdings, insider activity, and 13F data for Insulet Corporation are premium features in Vest Terminal.
Ownership & insider analytics is available in Vest Terminal for Professional and Enterprise subscribers.
Start Free — open PODD in Vest Terminal
Access live data, filings, ownership, and analysis for Insulet Corporation.
Insulet Corporation FAQ
What does Insulet Corporation (PODD) do?
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes…
What is PODD's P/E ratio?
Insulet Corporation has a trailing P/E of 25.61× based on publicly available market data.
Does PODD pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is PODD in?
Insulet Corporation is classified in Healthcare (Medical Devices) on NMS.
What is PODD's market capitalization?
Approximate market cap: $9.47B.
What are the main risks for PODD?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of PODD?
Potential positives include revenue growth of 23.5% year-over-year, earnings growth of 3.3% year-over-year.
Where can I get analyst estimates for PODD?
Public analyst price targets and consensus for Insulet Corporation are on the free /stocks/podd/estimates page. Deeper estimate history and models are available in Vest Terminal.